---
figid: PMC6125328__fimmu-09-01927-g0004
figlink: /pmc/articles/PMC6125328/figure/F4/
number: Figure 4
caption: CARMA/CARD-dependent and-independent MALT1 activation. (A) In the depicted
  T cell malignancies, gain-of-function mutations in CARMA1 or its upstream regulators
  or in-frame gene fusions of the T-cell co-receptor CD28 with ICOS or CTLA-4 are
  thought to promote MALT1 constitutive activation. (B) In the indicated B-cell lymphomas
  constitutive MALT1 protease activity can be driven by oncogenic mutations in CARMA1,
  CD79A or CD79B, which may be relevant in combination with self-antigen recognition.
  A subset of MCL and CLL are also addicted to this pathway by unknown mechanisms.
  (C) A large proportion of MALT lymphoma harbors a chromosomal translocation leading
  to formation of an oncogenic MALT1-API2 fusion protein. (D) In primary effusion
  lymphoma (PEL), NF-κB is activated through viral latency proteins such as K13 and
  K15, which activate NF-κB directly or via MALT1-BCL10. (A,B), mutations and self-antigen
  are depicted with a yellow star. (A,D) Open questions are depicted with red question
  marks. PTCL, peripheral T-cell lymphoma; ATLL adult T-cell leukemia/lymphoma; ABC,
  activated B-cell subtype; DLBCL, diffuse large B-cell lymphoma; BENTA, B-cell expansion
  with NF-κB and T-cell anergy; MCL, mantle cell lymphoma; CLL, chronic lymphocytic/leukemia.
pmcid: PMC6125328
papertitle: 'Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling.'
reftext: Mélanie Juilland, et al. Front Immunol. 2018;9:1927.
pmc_ranked_result_index: '193846'
pathway_score: 0.8644114
filename: fimmu-09-01927-g0004.jpg
figtitle: CARMA/CARD-dependent and-independent MALT1 activation
year: '2018'
organisms: Homo sapiens
ndex: ae6a9dfd-df03-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6125328__fimmu-09-01927-g0004.html
  '@type': Dataset
  description: CARMA/CARD-dependent and-independent MALT1 activation. (A) In the depicted
    T cell malignancies, gain-of-function mutations in CARMA1 or its upstream regulators
    or in-frame gene fusions of the T-cell co-receptor CD28 with ICOS or CTLA-4 are
    thought to promote MALT1 constitutive activation. (B) In the indicated B-cell
    lymphomas constitutive MALT1 protease activity can be driven by oncogenic mutations
    in CARMA1, CD79A or CD79B, which may be relevant in combination with self-antigen
    recognition. A subset of MCL and CLL are also addicted to this pathway by unknown
    mechanisms. (C) A large proportion of MALT lymphoma harbors a chromosomal translocation
    leading to formation of an oncogenic MALT1-API2 fusion protein. (D) In primary
    effusion lymphoma (PEL), NF-κB is activated through viral latency proteins such
    as K13 and K15, which activate NF-κB directly or via MALT1-BCL10. (A,B), mutations
    and self-antigen are depicted with a yellow star. (A,D) Open questions are depicted
    with red question marks. PTCL, peripheral T-cell lymphoma; ATLL adult T-cell leukemia/lymphoma;
    ABC, activated B-cell subtype; DLBCL, diffuse large B-cell lymphoma; BENTA, B-cell
    expansion with NF-κB and T-cell anergy; MCL, mantle cell lymphoma; CLL, chronic
    lymphocytic/leukemia.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLCG2
  - TRA
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKCB
  - PLCG1
  - CTLA4
  - ICOS
  - MALT1
  - CLEC4D
  - PRKD3
  - PRKCA
  - PRKCD
  - PRKCE
  - CARD11
  - CD28
  - TRG
  - TRB
  - TRD
  - KRT15
  - TSPYL2
  - BCL10
  - BCR
  - IKBKB
  - IKBKG
  - CHUK
  - TCR
  - Lymphomas
  - MCL
  - MALT Lymphoma
  - Primary effusion lymphoma
  - PKCD
genes:
- word: PLCY2
  symbol: PLCG2
  source: hgnc_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKCB
  symbol: PKCB
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: (PLCY1
  symbol: PLCG1
  source: hgnc_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: CTLA4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: ICOS
  symbol: ICOS
  source: hgnc_symbol
  hgnc_symbol: ICOS
  entrez: '29851'
- word: MALT1
  symbol: MALT1
  source: hgnc_symbol
  hgnc_symbol: MALT1
  entrez: '10892'
- word: MCL,
  symbol: MCL
  source: hgnc_alias_symbol
  hgnc_symbol: CLEC4D
  entrez: '338339'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: CARMA1
  symbol: CARMA1
  source: hgnc_alias_symbol
  hgnc_symbol: CARD11
  entrez: '84433'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: K15
  symbol: K15
  source: hgnc_alias_symbol
  hgnc_symbol: KRT15
  entrez: '3866'
- word: ATLL,PTCL,CTCL,SézaryABC,MCL,CLL,BENTA
  symbol: CTCL
  source: hgnc_alias_symbol
  hgnc_symbol: TSPYL2
  entrez: '64061'
- word: BCL10
  symbol: BCL10
  source: hgnc_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
diseases:
- word: Lymphomas
  source: MESH
  identifier: D008223
- word: MCL
  source: MESH
  identifier: C535516
- word: MALT Lymphoma
  source: MESH
  identifier: D018442
- word: Primary effusion lymphoma
  source: MESH
  identifier: D054685
- word: PKCD
  source: ''
  identifier: ''
---
